Phase II/III CRO Benchmarking (13th Ed.)

Description

We know many sponsor companies turn to CROs for the heavy lifting of their clinical development programs. Finding the service provider best suited to meet trial needs and ensuring that provider can meet performance expectations constitutes the onerous and time-intensive decision-making process that companies take on if they need to outsource any or all components of their clinical trials. In other words, companies need a reliable resource to shed light on CRO selection and CRO performance. This report is that resource. We aim to alleviate some of the stress associated with this process by enhancing your ability to make informed decisions.

This year’s report includes insights from 237 experienced Phase II/III outsourcers and more than 800 service provider encounters. Want to learn what the outsourcing community considers when it comes to CRO selection? Or how to get a sense of a provider’s brand positioning, customer loyalty, and attribute-specific strengths and weaknesses? Whether you’re a sponsor or provider, use this research to glean what you need to make the best decisions possible for your clinical development programs and service offerings.

"PHASE II/III CRO BENCHMARKING" Preview cover

Sponsors:

  • Discover which service providers your company should consider for your clinical development programs by seeing how your peers’ expectations line up with individual CROs
  • Gain insight into CRO customer loyalty based on overall customer satisfaction, willingness to recommend and likelihood to use again
  • Learn which Phase II/III-specific attributes drive outsourcing selection, and explore verbatim responses from recent customers on CRO performance

Service Providers:

  • Compare how your company matches up against your competitors across 21 attributes grouped by Budget, Delivery, Staff and Services
  • Learn how to improve your marketing messaging by focusing on the areas in which customers say you excel compared to the competition
  • Find out which factors affect sponsor outsourcing preferences, and which factors are gaining in importance for future outsourcing
  • Service Provider Selection Process
  • Service Provider Perceptions and Interactions
  • Service Provider Performance and Loyalty
  • Company Service Quality Profiles

ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive

  • Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
  • Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries.  We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
  • Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.

For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.

"For Pharma Project Managers" A sample page for Phase II/III CRO Benchmarking (13th Ed.)

Service Provider Selection Process

Primary Section Takeaways
Preferred Provider Agreements
Selection Attributes
Use of Outside Consultants for CRO Identification and Selection
Select Respondent Comments

Service Provider Perceptions and Interactions

Primary Section Takeaways
Phase II/III Leadership, Familiarity, and Use
Service Provider Preference
Service Provider Preference among Users
Cost Perceptions
Cost Experience among Users
Summary Table

Service Provider Performance and Loyalty

Primary Section Takeaways
A Note on Harvey Ball Calculations
Performance Across Service Providers
Figure 1 – Budget Factors
Figure 2 – Delivery Factors
Figure 3 – Staff Characteristics
Figure 4 – Services
Customer Loyalty: 2021
Customer Loyalty: 3-Year Rolling Average

Company Service Quality Profiles

Bioclinica
Covance
Eurofins
ICON
IQVIA
Medpace
Parexel
Pharm-Olam International
PPD
PRA
Syneos Health
Synteract
Worldwide Clinical Trials

Study Data

Phase II/III Leaders, Unprompted
Phase II/III Leaders, Prompted
Service Provider Familiarity
Service Provider Familiarity – Additional Providers
Service Provider Usage
Service Provider Preference
Service Provider Differentiation
Service Provider Cost Perceptions
Use of Preferred Providers
Number of Preferred Providers
Selection Drivers: Selecting among Preferred Providers
Preferred Provider Attributes Gaining Importance
Selection Drivers: When Not Using Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance: No Preferred Providers
Use of Outside Consultants for CRO Identification and Selection
Outside Consultant Assistance
Service Provider Drill-downs

Advanced Clinical
Bioclinica
Clinical Research Services (CRS)
Clinipace
Clintec
Covance
CTI Clinical Trial & Consulting
DaVita Clinical Research
DCRI-Duke
Eurofins
Frontage
George Clinical
ICON
Innovaderm
IQVIA
Linical Accelovance
Medpace
Medsource
MMS Holdings
NAMSA
Navitas Life Sciences
Novotech
Ora
Parexel
Pharm-Olam International
PharPoint
PPD
PRA
Premier Research
PSI
QPS
Rho
SGS Life Sciences
Syneos Health
Synteract
Worldwide Clinical Trials

Demographics

Company Type
Headquarters Location
Office Location
Job Title
Decision-making Responsibility
Outsourcing Involvement by Phase
Involvement in Clinical Development
Therapeutic Areas of Responsibility
Years of Industry Experience
Age

Additional information

License

, ,